诚意药业：托拉塞米片获药品注册证书

Core Viewpoint - The company has received approval from the National Medical Products Administration for the registration of Torasemide tablets, indicating a significant step in its product development and market entry [1] Group 1: Product Approval - The approved specifications for Torasemide tablets are 5mg and 10mg, classified as Category 4 chemical drugs, which is equivalent to passing the consistency evaluation for generic drugs [1] - The registration application for the product was submitted on July 2, 2024, and has been accepted [1] Group 2: Market Context - A total of six manufacturers have received approval for the product, indicating a competitive landscape [1] - The product is not included in the national centralized drug procurement catalog, which may affect its market penetration and pricing strategy [1] Group 3: Financial Investment - The company has invested 10.9941 million yuan in the research and development of Torasemide tablets [1] Group 4: Potential Challenges - The production and sales of the pharmaceutical product may be influenced by uncertain factors due to the nature of medical products [1]